PRF Technologies (PRFX) Net Cash Flow Growth (3y) (2023 - 2024)

PRF Technologies (PRFX) Net Cash Flow Growth (3y) (2023 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 32.03%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 28.99%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -49.94%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -41.05%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -62.71%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -205.66%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -59.10%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 36.11%
10 PRF Technologies 933,081.16 -2.46 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 60.81%
Mar 31, 2024 -44.03%
Dec 31, 2023 30.68%
Sep 30, 2023 -48.00%
Jun 30, 2023 -210.83%
Mar 31, 2023 175.14%